{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T05:15:55Z","timestamp":1768972555890,"version":"3.49.0"},"reference-count":37,"publisher":"Keio Journal of Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Keio J. Med.","Keio j. med"],"published-print":{"date-parts":[[2025]]},"DOI":"10.2302\/kjm.2023-0008-ir","type":"journal-article","created":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T22:14:53Z","timestamp":1687990493000},"page":"11-20","source":"Crossref","is-referenced-by-count":3,"title":["Recent Advances in Clinical Research on Rare Intractable Hereditary          Skin Diseases in Japan"],"prefix":"10.2302","volume":"74","author":[{"given":"Masashi","family":"Akiyama","sequence":"first","affiliation":[{"name":"Department of Dermatology, Nagoya University Graduate              School of Medicine, Nagoya, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Takeichi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Nagoya University Graduate              School of Medicine, Nagoya, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigaku","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergology, Juntendo              University Graduate School of Medicine, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Ishiko","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Toho University School of              Medicine, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiko","family":"Kurosawa","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Environmental Health,              Juntendo University Faculty of Medicine, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Murota","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Nagasaki University Graduate              School of Biomedical Sciences, Nagasaki, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Shimomura","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Yamaguchi University              Graduate School of Medicine, Ube, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamio","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Yamagata University Faculty              of Medicine, Yamagata, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuto","family":"Tamai","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Therapy Science, Osaka              University Graduate School of Medicine, Suita, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Graduate School of              Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Terui","sequence":"additional","affiliation":[{"name":"Division of Cutaneous Science, Department of              Dermatology, Nihon University School of Medicine, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Amagai","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Keio University School of              Medicine, Tokyo, Japan"},{"name":"Laboratory for Skin Homeostasis, RIKEN Center for              Integrative Medical Sciences, Kanagawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1082","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Has C, Bauer JW, Bodemer C, Bolling MC,          Bruckner-Tuderman L, Diem A, Fine JD, Heagerty A, Hovnanian A, Marinkovich MP, Martinez          AE, McGrath JA, Moss C, Murrell DF, Palisson F, Schwieger-Briel A, Sprecher E, Tamai K,          Uitto J, Woodley DT, Zambruno G, Mellerio JE: Consensus reclassification of inherited          epidermolysis bullosa and other disorders with skin fragility. Br J Dermatol 2020; 183:          614\u2013627. PMID:32017015 https:\/\/doi.org\/10.1111\/bjd.18921","DOI":"10.1111\/bjd.18921"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Yoshida K, Kobayashi M, Matsunaga Y, Kubo A,          Ishiko A: Case of intermediate recessive dystrophic epidermolysis bullosa with negative          LH7.2 staining. J Dermatol 2020; 47: e370\u2013e372. PMID:32656782          https:\/\/doi.org\/10.1111\/1346-8138.15498","DOI":"10.1111\/1346-8138.15498"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Mori S, Shimbo T, Kimura Y, Hayashi M, Kiyohara          E, Fukui M, Watanabe M, Bessho K, Fujimoto M, Tamai K: Recessive dystrophic epidermolysis          bullosa with extensive transplantation of cultured epidermal autograft product after          cardiopulmonary resuscitation: a case report. J Dermatol 2021; 48: e194\u2013e195.          PMID:33609402 https:\/\/doi.org\/10.1111\/1346-8138.15798","DOI":"10.1111\/1346-8138.15798"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Fujita Y, Nohara T, Takashima S, Natsuga K,          Adachi M, Yoshida K, Shinkuma S, Takeichi T, Nakamura H, Wada O, Akiyama M, Ishiko A,          Shimizu H: Intravenous allogeneic multilineage\u2010differentiating stress\u2010enduring cells in          adults with dystrophic epidermolysis bullosa: a phase 1\/2 open\u2010label study. J Eur Acad          Dermatol Venereol 2021; 35: e528\u2013e531. PMID:33656198          https:\/\/doi.org\/10.1111\/jdv.17201","DOI":"10.1111\/jdv.17201"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Takaki S, Shimbo T, Ikegami K, Kitayama T,          Yamamoto Y, Yamazaki S, Mori S, Tamai K: Generation of a recessive dystrophic          epidermolysis bullosa mouse model with patient-derived compound heterozygous mutations.          Lab Invest 2022; 102: 574\u2013580. PMID:35152273          https:\/\/doi.org\/10.1038\/s41374-022-00735-5","DOI":"10.1038\/s41374-022-00735-5"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Vahlquist A, Fischer J, T\u00f6rm\u00e4 H: Inherited          nonsyndromic ichthyoses: an update on pathophysiology, diagnosis and treatment. Am J Clin          Dermatol 2018; 19: 51\u201366. PMID:28815464          https:\/\/doi.org\/10.1007\/s40257-017-0313-x","DOI":"10.1007\/s40257-017-0313-x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Akiyama M: Acylceramide is a key player in skin          barrier function: insight into the molecular mechanisms of skin barrier formation and          ichthyosis pathogenesis. FEBS J 2021; 288: 2119\u20132130.          https:\/\/doi.org\/10.1111\/febs.15497","DOI":"10.1111\/febs.15497"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Guti\u00e9rrez-Cerrajero C, Sprecher E, Paller AS,          Akiyama M, Mazereeuw-Hautier J, Hern\u00e1ndez-Mart\u00edn A, Gonz\u00e1lez-Sarmiento R: Ichthyosis. Nat          Rev Dis Primers 2023; 9: 2. PMID:36658163          https:\/\/doi.org\/10.1038\/s41572-022-00412-3","DOI":"10.1038\/s41572-022-00412-3"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Murase C, Takeichi T, Shibata A, Nakatochi M,          Kinoshita F, Kubo A, Nakajima K, Ishii N, Amano H, Masuda K, Kawakami H, Kanekura T,          Washio K, Asano M, Teramura K, Akasaka E, Tohyama M, Hatano Y, Ochiai T, Moriwaki S, Sato          T, Ishida-Yamamoto A, Seishima M, Kurosawa M, Ikeda S, Akiyama M: Cross-sectional survey          on disease severity in Japanese patients with harlequin ichthyosis\/ichthyosis: syndromic          forms and quality-of-life analysis in a subgroup. J Dermatol Sci 2018; 92: 127\u2013133.          PMID:30241690 https:\/\/doi.org\/10.1016\/j.jdermsci.2018.08.008","DOI":"10.1016\/j.jdermsci.2018.08.008"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kurosawa M, Uehara R, Takagi A, Aoyama Y,          Iwatsuki K, Amagai M, Nagai M, Nakamura Y, Inaba Y, Yokoyama K, Ikeda S: Results of a          nationwide epidemiologic survey of autosomal recessive congenital ichthyosis and          ichthyosis syndromes in Japan. J Am Acad Dermatol 2019; 81: 1086\u20131092. PMID:30268591          https:\/\/doi.org\/10.1016\/j.jaad.2018.07.056","DOI":"10.1016\/j.jaad.2018.07.056"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Takeichi T, Hirabayashi T, Miyasaka Y, Kawamoto          A, Okuno Y, Taguchi S, Tanahashi K, Murase C, Takama H, Tanaka K, Boeglin WE, Calcutt MW,          Watanabe D, Kono M, Muro Y, Ishikawa J, Ohno T, Brash AR, Akiyama M: SDR9C7 catalyzes          critical dehydrogenation of acylceramides for skin barrier formation. J Clin Invest 2020;          130: 890\u2013903. PMID:31671075 https:\/\/doi.org\/10.1172\/JCI130675","DOI":"10.1172\/JCI130675"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Murase C, Takeichi T, Taki T, Yoshikawa T, Suzuki          A, Ogi T, Suga Y, Akiyama M: Successful dupilumab treatment for ichthyotic and atopic          features of Netherton syndrome. J Dermatol Sci 2021; 102: 126\u2013129. PMID:33773888          https:\/\/doi.org\/10.1016\/j.jdermsci.2021.03.003","DOI":"10.1016\/j.jdermsci.2021.03.003"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Okamura K, Suzuki T: Current landscape of          oculocutaneous albinism in Japan. Pigment Cell Melanoma Res 2021; 34: 190\u2013203.          PMID:32969595 https:\/\/doi.org\/10.1111\/pcmr.12927","DOI":"10.1111\/pcmr.12927"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Fern\u00e1ndez A, Hayashi M, Garrido G, Montero A,          Guardia A, Suzuki T, Montoliu L: Genetics of non\u2010syndromic and syndromic oculocutaneous          albinism in human and mouse. Pigment Cell Melanoma Res 2021; 34: 786\u2013799. PMID:33960688          https:\/\/doi.org\/10.1111\/pcmr.12982","DOI":"10.1111\/pcmr.12982"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Okamura K, Hayashi M, Abe Y, Kono M, Nakajima K,          Aoyama Y, Nishigori C, Ishimoto H, Ishimatsu Y, Nakajima M, Hozumi Y, Suzuki T: NGS\u2010based          targeted resequencing identified rare subtypes of albinism: providing accurate molecular          diagnosis for Japanese patients with albinism. Pigment Cell Melanoma Res 2019; 32:          848\u2013853. PMID:31141302 https:\/\/doi.org\/10.1111\/pcmr.12800","DOI":"10.1111\/pcmr.12800"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Saito T, Okamura K, Funasaka Y, Abe Y, Suzuki T:          Identification of two novel mutations in a Japanese patient with Hermansky\u2013Pudlak syndrome          type 5. J Dermatol 2020; 47: e392\u2013e393. PMID:32881069          https:\/\/doi.org\/10.1111\/1346-8138.15560","DOI":"10.1111\/1346-8138.15560"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Saito T, Okamura K, Kosaki R, Wakamatsu K, Ito S,          Nakajima O, Yamashita H, Hozumi Y, Suzuki T: Impact of a SLC24A5 variant on the retinal          pigment epithelium of a Japanese patient with oculocutaneous albinism type 6. Pigment Cell          Melanoma Res 2022; 35: 212\u2013219. PMID:34870899          https:\/\/doi.org\/10.1111\/pcmr.13024","DOI":"10.1111\/pcmr.13024"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Iwanaga A, Utani A, Koike Y, Okubo Y, Kuwatsuka          Y, Endo Y, Tanizaki H, Wataya-Kaneda M, Hatamochi A, Minaga K, Ogi T, Yamamoto Y, Ikeda S,          Tsuiki E, Tamura H, Maemura K, Kitaoka T, Murota H: Clinical practice guidelines for          pseudoxanthoma elasticum (2017): Clinical Practice Guidelines for Pseudoxanthoma Elasticum          Drafting Committee. J Dermatol 2022; 49: e91\u2013e98. PMID:35019155          https:\/\/doi.org\/10.1111\/1346-8138.16301","DOI":"10.1111\/1346-8138.16301"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Yamazaki Y, Iwanaga A, Koike Y, Sato T, Murota H,          Takeuchi M, Satoh T: A possible case of pseudoxanthoma elasticum (PXE) with          histopathological features of PXE\u2010like papillary dermal elastolysis. J Dermatol 2021; 48:          e265\u2013e266. PMID:33759225 https:\/\/doi.org\/10.1111\/1346-8138.15859","DOI":"10.1111\/1346-8138.15859"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Maurer M, Magerl M, Betschel S, Aberer W,          Ansotegui IJ, Ayg\u00f6ren-P\u00fcrs\u00fcn E, Banerji A, Bara NA, Boccon-Gibod I, Bork K, Bouillet L,          Boysen HB, Brodszki N, Busse PJ, Bygum A, Caballero T, Cancian M, Castaldo A, Cohn DM,          Csuka D, Farkas H, Gompels M, Gower R, Grumach AS, Guidos-Fogelbach G, Hide M, Kang HR,          Kaplan AP, Katelaris C, Kiani-Alikhan S, Lei WT, Lockey R, Longhurst H, Lumry WR,          MacGinnitie A, Malbran A, Martinez Saguer I, Matta JJ, Nast A, Nguyen D, Nieto-Martinez          SA, Pawankar R, Peter J, Porebski G, Prior N, Reshef A, Riedl M, Ritchie B, Rafique Sheikh          F, Smith WB, Spaeth PJ, Stobiecki M, Toubi E, Varga LA, Weller K, Zanichelli A, Zhi Y,          Zuraw B, Craig T: The international WAO\/EAACI guideline for the management of hereditary          angioedema\u2014the 2021 revision and update. Allergy 2022; 77: 1961\u20131990. PMID:35006617          https:\/\/doi.org\/10.1111\/all.15214","DOI":"10.1111\/all.15214"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Weller K, Groffik A, Magerl M, Tohme N, Martus P,          Krause K, Metz M, Staubach P, Maurer M: Development and construct validation of the          angioedema quality of life questionnaire. Allergy 2012; 67: 1289\u20131298. PMID:22913638          https:\/\/doi.org\/10.1111\/all.12007","DOI":"10.1111\/all.12007"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Weller K, Donoso T, Magerl M, Ayg\u00f6ren-P\u00fcrs\u00fcn E,          Staubach P, Martinez-Saguer I, Hawro T, Altrichter S, Krause K, Siebenhaar F, Metz M,          Zuberbier T, Freier D, Maurer M: Validation of the angioedema control test (AECT)\u2014a          patient-reported outcome instrument for assessing angioedema control. J Allergy Clin          Immunol Pract 2020; 8: 2050\u20132057. PMID:32173507          https:\/\/doi.org\/10.1016\/j.jaip.2020.02.038","DOI":"10.1016\/j.jaip.2020.02.038"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Morioke S, Takahagi S, Kawano R, Fukunaga A,          Harada S, Ohsawa I, Masuda K, Irifuku R, Yokobayashi H, Kameyoshi Y, Tanaka A, Tamari S,          Hide M: A validation study of the Japanese version of the Angioedema Activity Score (AAS)          and the Angioedema Quality of Life Questionnaire (AE-QoL). Allergol Int 2021; 70: 471\u2013479.          PMID:34023225 https:\/\/doi.org\/10.1016\/j.alit.2021.04.006","DOI":"10.1016\/j.alit.2021.04.006"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Maurer M, Magerl M, Ansotegui I, Ayg\u00f6ren-P\u00fcrs\u00fcn          E, Betschel S, Bork K, Bowen T, Balle Boysen H, Farkas H, Grumach AS, Hide M, Katelaris C,          Lockey R, Longhurst H, Lumry WR, Martinez-Saguer I, Moldovan D, Nast A, Pawankar R, Potter          P, Riedl M, Ritchie B, Rosenwasser L, S\u00e1nchez-Borges M, Zhi Y, Zuraw B, Craig T: The          international WAO\/EAACI guideline for the management of hereditary angioedema\u2014the 2017          revision and update. Allergy 2018; 73: 1575\u20131596. PMID:29318628          https:\/\/doi.org\/10.1111\/all.13384","DOI":"10.1111\/all.13384"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Yasuno S, Ansai O, Hayashi R, Nakamura S,          Shimomura Y: Evidence for a dominant\u2010negative effect of a missense mutation in the          SERPING1 gene responsible for hereditary angioedema type I. J Dermatol 2021; 48:          1243\u20131249. PMID:33914953 https:\/\/doi.org\/10.1111\/1346-8138.15930","DOI":"10.1111\/1346-8138.15930"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Iwamoto K, Yamamoto B, Ohsawa I, Honda D,          Horiuchi T, Tanaka A, Fukunaga A, Maehara J, Yamashita K, Akita T, Hide M: The diagnosis          and treatment of hereditary angioedema patients in Japan: a patient reported outcome          survey. Allergol Int 2021; 70: 235\u2013243. PMID:33168485          https:\/\/doi.org\/10.1016\/j.alit.2020.09.008","DOI":"10.1016\/j.alit.2020.09.008"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Hide M, Horiuchi T, Ohsawa I, Andresen I,          Fukunaga A: Management of hereditary angioedema in Japan: focus on icatibant for the          treatment of acute attacks. Allergol Int 2021; 70: 45\u201354. PMID:32919903          https:\/\/doi.org\/10.1016\/j.alit.2020.07.008","DOI":"10.1016\/j.alit.2020.07.008"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Saito R, Takahagi S, Nakano F, Furutani K, Mihara          S, Numata T, Kameyoshi Y, Tanaka T, Shindo H, Niimi N, Iwamoto K, Hiragun T, Hiragun M,          Tanaka A, Hide M: A survey on subtypes and clinical characteristics of 1061 patients with          urticaria in the primary care institutes in Japan. J Dermatol 2022; 49: 1255\u20131262.          PMID:36028980 https:\/\/doi.org\/10.1111\/1346-8138.16562","DOI":"10.1111\/1346-8138.16562"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Akiyama M, Takeichi T, McGrath JA, Sugiura K:          Autoinflammatory keratinization diseases. J Allergy Clin Immunol 2017; 140: 1545\u20131547.          PMID:28668225 https:\/\/doi.org\/10.1016\/j.jaci.2017.05.019","DOI":"10.1016\/j.jaci.2017.05.019"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Akiyama M: Pustular psoriasis as an          autoinflammatory keratinization disease (AiKD): genetic predisposing factors and promising          therapeutic targets. J Dermatol Sci 2022; 105: 11\u201317. PMID:34973880          https:\/\/doi.org\/10.1016\/j.jdermsci.2021.11.009","DOI":"10.1016\/j.jdermsci.2021.11.009"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Sugiura K, Takemoto A, Yamaguchi M, Takahashi H,          Shoda Y, Mitsuma T, Tsuda K, Nishida E, Togawa Y, Nakajima K, Sakakibara A, Kawachi S,          Shimizu M, Ito Y, Takeichi T, Kono M, Ogawa Y, Muro Y, Ishida-Yamamoto A, Sano S, Matsue          H, Morita A, Mizutani H, Iizuka H, Muto M, Akiyama M: The majority of generalized pustular          psoriasis without psoriasis vulgaris is caused by deficiency of interleukin-36 receptor          antagonist. J Invest Dermatol 2013; 133: 2514\u20132521. PMID:23698098          https:\/\/doi.org\/10.1038\/jid.2013.230","DOI":"10.1038\/jid.2013.230"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Akiyama M: Early-onset generalized pustular          psoriasis is representative of autoinflammatory keratinization diseases. J Allergy Clin          Immunol 2019; 143: 809\u2013810. PMID:30606494          https:\/\/doi.org\/10.1016\/j.jaci.2018.11.009","DOI":"10.1016\/j.jaci.2018.11.009"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Hayama K, Fujita H, Iwatsuki K, Terui T: Improved          quality of life of patients with generalized pustular psoriasis in Japan: a          cross\u2010sectional survey. J Dermatol 2021; 48: 203\u2013206. PMID:33099802          https:\/\/doi.org\/10.1111\/1346-8138.15657","DOI":"10.1111\/1346-8138.15657"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Fujita H, Terui T, Hayama K, Akiyama M, Ikeda S,          Mabuchi T, Ozawa A, Kanekura T, Kurosawa M, Komine M, Nakajima K, Sano S, Nemoto O, Muto          M, Imai Y, Yamanishi K, Aoyama Y, Iwatsuki K, Japanese Dermatological Association          Guidelines Development Committee for the Guidelines for the Management and Treatment of          Generalized Pustular Psoriasis: Japanese guidelines for the management and treatment of          generalized pustular psoriasis: the new pathogenesis and treatment of GPP. J Dermatol          2018; 45: 1235\u20131270. PMID:30230572          https:\/\/doi.org\/10.1111\/1346-8138.14523","DOI":"10.1111\/1346-8138.14523"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Hayama K, Fujita H, Terui T: Current trend in the          treatment of generalized pustular psoriasis in Japan: results from a questionnaire\u2010based          epidemiological study. J Dermatol 2022; 49: e439\u2013e440. PMID:35876178          https:\/\/doi.org\/10.1111\/1346-8138.16530","DOI":"10.1111\/1346-8138.16530"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Manone-Zenke Y, Ohara Y, Fukui S, Kobayashi D,          Sugiura K, Ikeda S, Arai S: Characteristics of patients with generalized pustular          psoriasis and psoriatic arthritis: a retrospective cohort study. Acta Derm Venereol 2022;          102: adv00685. PMID:35312017 https:\/\/doi.org\/10.2340\/actadv.v102.2226","DOI":"10.2340\/actadv.v102.2226"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Onitsuka M, Farooq M, Iqbal MN, Yasuno S,          Shimomura Y: A homozygous loss-of-function variant in the MPO gene is associated with          generalized pustular psoriasis. J Dermatol 2023; 50: 664\u2013671. PMID:36585391          PMID:36585391https:\/\/doi.org\/10.1111\/1346-8138.16700","DOI":"10.1111\/1346-8138.16700"}],"container-title":["The Keio Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/kjm\/74\/1\/74_2023-0008-IR\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T04:06:17Z","timestamp":1743221177000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/kjm\/74\/1\/74_2023-0008-IR\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2302\/kjm.2023-0008-ir","relation":{},"ISSN":["0022-9717","1880-1293"],"issn-type":[{"value":"0022-9717","type":"print"},{"value":"1880-1293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"2023-0008-IR"}}